07 Jan 2001

Losferron (ferrogluconaat) - Nederland

Losferron Description, Presentation and Dosage

Losferron Description

Losferron Drug Class Description

Volwassenen: Bruistablet: 1 bruistablet per dag, zo nodig bij ernstige bloedarmoede verhogen tot 2-3 bruistabletten per dag in 2-3 gelijke doses. Drank: 6 ml driemaal per dag. Kinderen: Drank: 3 mg Fe++/kg lichaamsgewicht per dag in 3 giften (1 mg Fe++ komt overeen met 0,12 ml); bijvoorbeeld: 8 maanden: 1 ml driemaal per dag; 4 jaar: 2 ml driemaal per dag; 8 jaar: 3 ml driemaal per dag. De bruistablet opgelost in een glas water een / uur voor de maaltijd innemen. De drank bij voorkeur innemen op een lege maag, bij optreden van maagklachten na de maaltijd.

Losferron Generic Name


Losferron Presentation

Losferron Presentation

Bruistablet 695 mg (Fe++ 80 mg). Bevat per tablet 214,5 mg natrium.

Losferron Manufacturer


Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Losferron Dosage

Losferron Precautions, Reactions and Contraindications

Losferron Special Precautions

Related Drugs - Haematology

Back to top